Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092443840> ?p ?o ?g. }
- W3092443840 endingPage "565" @default.
- W3092443840 startingPage "553" @default.
- W3092443840 abstract "In personalized medicine, predictive biomarker testing is the basis for an appropriate choice of therapy for patients with cancer. An important tool for laboratories to ensure accurate results is participation in external quality assurance (EQA) programs. Several providers offer predictive EQA programs for different cancer types, test methods, and sample types. In 2013, a guideline was published on the requirements for organizing high-quality EQA programs in molecular pathology. Now, after six years, steps were taken to further harmonize these EQA programs as an initiative by IQNPath ABSL, an umbrella organization founded by various EQA providers. This revision is based on current knowledge, adds recommendations for programs developed for predictive biomarkers by in situ methodologies (immunohistochemistry and in situ hybridization), and emphasized transparency and an evidence-based approach. In addition, this updated version also has the aim to give an overview of current practices from various EQA providers." @default.
- W3092443840 created "2020-10-15" @default.
- W3092443840 creator A5003014678 @default.
- W3092443840 creator A5003573806 @default.
- W3092443840 creator A5005465971 @default.
- W3092443840 creator A5011155181 @default.
- W3092443840 creator A5017477381 @default.
- W3092443840 creator A5020930480 @default.
- W3092443840 creator A5024727242 @default.
- W3092443840 creator A5028977001 @default.
- W3092443840 creator A5039134651 @default.
- W3092443840 creator A5049482844 @default.
- W3092443840 creator A5053902514 @default.
- W3092443840 creator A5055055840 @default.
- W3092443840 creator A5058774502 @default.
- W3092443840 creator A5064777251 @default.
- W3092443840 creator A5071962604 @default.
- W3092443840 creator A5072041665 @default.
- W3092443840 creator A5074819403 @default.
- W3092443840 creator A5079795218 @default.
- W3092443840 creator A5090177578 @default.
- W3092443840 creator A5090388856 @default.
- W3092443840 date "2020-10-13" @default.
- W3092443840 modified "2023-09-26" @default.
- W3092443840 title "Biomarker testing in oncology – Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL" @default.
- W3092443840 cites W1037076944 @default.
- W3092443840 cites W1949802540 @default.
- W3092443840 cites W1956163040 @default.
- W3092443840 cites W1965123251 @default.
- W3092443840 cites W1997241015 @default.
- W3092443840 cites W2101478267 @default.
- W3092443840 cites W2110063153 @default.
- W3092443840 cites W2115325071 @default.
- W3092443840 cites W2118272646 @default.
- W3092443840 cites W2150013445 @default.
- W3092443840 cites W2229116738 @default.
- W3092443840 cites W2279539442 @default.
- W3092443840 cites W2309021002 @default.
- W3092443840 cites W2328762559 @default.
- W3092443840 cites W2419311181 @default.
- W3092443840 cites W2481433613 @default.
- W3092443840 cites W2554948810 @default.
- W3092443840 cites W2558317280 @default.
- W3092443840 cites W2568097384 @default.
- W3092443840 cites W2587683955 @default.
- W3092443840 cites W2594182012 @default.
- W3092443840 cites W2599352654 @default.
- W3092443840 cites W2619372531 @default.
- W3092443840 cites W2697484384 @default.
- W3092443840 cites W2733940275 @default.
- W3092443840 cites W2741424510 @default.
- W3092443840 cites W2749256247 @default.
- W3092443840 cites W2756216377 @default.
- W3092443840 cites W2759411970 @default.
- W3092443840 cites W2785259638 @default.
- W3092443840 cites W2801770572 @default.
- W3092443840 cites W2806074020 @default.
- W3092443840 cites W2883803660 @default.
- W3092443840 cites W2887351902 @default.
- W3092443840 cites W2888557945 @default.
- W3092443840 cites W2912717867 @default.
- W3092443840 cites W4235748407 @default.
- W3092443840 doi "https://doi.org/10.1007/s00428-020-02928-z" @default.
- W3092443840 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7550230" @default.
- W3092443840 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33047156" @default.
- W3092443840 hasPublicationYear "2020" @default.
- W3092443840 type Work @default.
- W3092443840 sameAs 3092443840 @default.
- W3092443840 citedByCount "11" @default.
- W3092443840 countsByYear W30924438402020 @default.
- W3092443840 countsByYear W30924438402022 @default.
- W3092443840 countsByYear W30924438402023 @default.
- W3092443840 crossrefType "journal-article" @default.
- W3092443840 hasAuthorship W3092443840A5003014678 @default.
- W3092443840 hasAuthorship W3092443840A5003573806 @default.
- W3092443840 hasAuthorship W3092443840A5005465971 @default.
- W3092443840 hasAuthorship W3092443840A5011155181 @default.
- W3092443840 hasAuthorship W3092443840A5017477381 @default.
- W3092443840 hasAuthorship W3092443840A5020930480 @default.
- W3092443840 hasAuthorship W3092443840A5024727242 @default.
- W3092443840 hasAuthorship W3092443840A5028977001 @default.
- W3092443840 hasAuthorship W3092443840A5039134651 @default.
- W3092443840 hasAuthorship W3092443840A5049482844 @default.
- W3092443840 hasAuthorship W3092443840A5053902514 @default.
- W3092443840 hasAuthorship W3092443840A5055055840 @default.
- W3092443840 hasAuthorship W3092443840A5058774502 @default.
- W3092443840 hasAuthorship W3092443840A5064777251 @default.
- W3092443840 hasAuthorship W3092443840A5071962604 @default.
- W3092443840 hasAuthorship W3092443840A5072041665 @default.
- W3092443840 hasAuthorship W3092443840A5074819403 @default.
- W3092443840 hasAuthorship W3092443840A5079795218 @default.
- W3092443840 hasAuthorship W3092443840A5090177578 @default.
- W3092443840 hasAuthorship W3092443840A5090388856 @default.
- W3092443840 hasBestOaLocation W30924438401 @default.
- W3092443840 hasConcept C106436119 @default.
- W3092443840 hasConcept C142724271 @default.
- W3092443840 hasConcept C151730666 @default.
- W3092443840 hasConcept C19527891 @default.